Andrew Dodgson

1.9k total citations
33 papers, 1.0k citations indexed

About

Andrew Dodgson is a scholar working on Infectious Diseases, Molecular Medicine and Epidemiology. According to data from OpenAlex, Andrew Dodgson has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 15 papers in Molecular Medicine and 10 papers in Epidemiology. Recurrent topics in Andrew Dodgson's work include Antibiotic Resistance in Bacteria (15 papers), Bacterial Identification and Susceptibility Testing (8 papers) and SARS-CoV-2 detection and testing (7 papers). Andrew Dodgson is often cited by papers focused on Antibiotic Resistance in Bacteria (15 papers), Bacterial Identification and Susceptibility Testing (8 papers) and SARS-CoV-2 detection and testing (7 papers). Andrew Dodgson collaborates with scholars based in United Kingdom, United States and Australia. Andrew Dodgson's co-authors include Andrew J. Fox, Claude Pujol, David R. Soll, Mathew Upton, Tarek M. Gibreel, David W. Denning, J. Cheesbrough, Michael A. Pfaller, Kirsty Dodgson and Neil Woodford and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Clinical Microbiology.

In The Last Decade

Andrew Dodgson

30 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Dodgson United Kingdom	17	434	417	405	291	153	33	1.0k
Ryoichi Saito Japan	19	257 0.6×	350 0.8×	447 1.1×	238 0.8×	213 1.4×	87	1.1k
Fernando Garcı́a-Garrote Spain	18	306 0.7×	379 0.9×	515 1.3×	413 1.4×	207 1.4×	42	1.2k
Timothy Kudinha Australia	24	557 1.3×	670 1.6×	528 1.3×	363 1.2×	270 1.8×	72	1.4k
An-Jing Kuo Taiwan	21	278 0.6×	389 0.9×	499 1.2×	237 0.8×	220 1.4×	33	1.1k
Johannes G.M. Koeleman Netherlands	13	475 1.1×	219 0.5×	352 0.9×	215 0.7×	197 1.3×	25	912
Eileen L. Lai Hong Kong	21	284 0.7×	339 0.8×	714 1.8×	368 1.3×	237 1.5×	30	1.1k
Sook-In Jung South Korea	18	318 0.7×	265 0.6×	462 1.1×	269 0.9×	208 1.4×	30	879
Kotaro Aoki Japan	18	362 0.8×	233 0.6×	344 0.8×	222 0.8×	293 1.9×	97	1.0k
Diego Faccone Argentina	20	222 0.5×	215 0.5×	624 1.5×	334 1.1×	246 1.6×	64	1.1k
Deborah Gascoyne‐Binzi United Kingdom	16	334 0.8×	367 0.9×	347 0.9×	187 0.6×	169 1.1×	25	891

Countries citing papers authored by Andrew Dodgson

Since Specialization

Citations

This map shows the geographic impact of Andrew Dodgson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Dodgson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Dodgson more than expected).

Fields of papers citing papers by Andrew Dodgson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Dodgson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Dodgson. The network helps show where Andrew Dodgson may publish in the future.

Co-authorship network of co-authors of Andrew Dodgson

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Dodgson. A scholar is included among the top collaborators of Andrew Dodgson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Dodgson. Andrew Dodgson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fowler, Tom, Andrew Dodgson, Jeanette Hall, et al.. (2025). Key SARS-CoV-2 testing strategies implemented in the UK: rationale and impact. Journal of the Royal Society of Medicine. 118(4). 112–120.

Futschik, Matthias E., Michael Kidd, Éamonn O’Moore, et al.. (2024). Faster detection of asymptomatic COVID-19 cases among care home staff in England through the combination of SARS-CoV-2 testing technologies. Scientific Reports. 14(1). 7475–7475.

Futschik, Matthias E., Samuel Johnson, David Chapman, et al.. (2024). Rapid antigen testing for SARS-CoV-2 by lateral flow assay: A field evaluation of self- and professional testing at UK community testing sites. Journal of Clinical Virology. 171. 105654–105654. 4 indexed citations

Fowler, Tom, David Chapman, Matthias E. Futschik, et al.. (2024). Self-swabbing versus assisted swabbing for viral detection by qRT-PCR: the experience from SARS-CoV-2 based on a meta-analysis of six prospectively designed evaluations conducted in a UK setting. European Journal of Clinical Microbiology & Infectious Diseases. 43(8). 1621–1630. 2 indexed citations

Fowler, Tom, David Chapman, Matthias E. Futschik, et al.. (2024). Comparative evaluation of swabbing sites for Omicron variant detection in PCR testing. Diagnostic Microbiology and Infectious Disease. 111(1). 116577–116577.

Eyre, David W., Matthias E. Futschik, Jia Wei, et al.. (2023). Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study. The Lancet Infectious Diseases. 23(8). 922–932. 32 indexed citations

Pople, Diane, Theodore Kypraios, Tjibbe Donker, et al.. (2023). Model-based evaluation of admission screening strategies for the detection and control of carbapenemase-producing Enterobacterales in the English hospital setting. BMC Medicine. 21(1). 492–492. 2 indexed citations

Goldenberg, Simon, Andrew Dodgson, Gavin Barlow, et al.. (2022). Epidemiology, Outcomes and Resource Utilisation in Patients with Carbapenem Non-susceptible Gram-Negative Bacteria in the UK: A Retrospective, Observational Study (CARBAR UK). Advances in Therapy. 39(8). 3602–3615. 6 indexed citations

Dodgson, Andrew, et al.. (2021). Cost-effectiveness analysis of vaborem for the treatment of carbapenem-resistant Enterobacteriaceae-Klebsiella pneumoniae carbapenemase (CRE-KPC) infections in the UK. The European Journal of Health Economics. 23(3). 537–549. 2 indexed citations

10.

Doumith, Michel, Jacqueline Findlay, Katie L. Hopkins, et al.. (2017). Major role of pKpQIL-like plasmids in the early dissemination of KPC-type carbapenemases in the UK. Journal of Antimicrobial Chemotherapy. 72(8). 2241–2248. 35 indexed citations

11.

Donker, Tjibbe, Katherine L. Henderson, Katie L. Hopkins, et al.. (2017). The relative importance of large problems far away versus small problems closer to home: insights into limiting the spread of antimicrobial resistance in England. BMC Medicine. 15(1). 86–86. 25 indexed citations

12.

Wilcox, Mark H., John Coia, Andrew Dodgson, et al.. (2017). Impact of recurrent Clostridium difficile infection: hospitalization and patient quality of life. Journal of Antimicrobial Chemotherapy. 72(9). 2647–2656. 52 indexed citations

13.

Krishnan, M., et al.. (2014). Brucella melitensis sternal osteomyelitis following median sternotomy. Journal of Infection and Chemotherapy. 20(9). 574–576. 4 indexed citations

14.

Alghoribi, Majed F., Tarek M. Gibreel, Andrew Dodgson, Scott A. Beatson, & Mathew Upton. (2014). Galleria mellonella Infection Model Demonstrates High Lethality of ST69 and ST127 Uropathogenic E. coli. PLoS ONE. 9(7). e101547–e101547. 60 indexed citations

15.

Hill-Cawthorne, Grant, Lyndsey O. Hudson, Moataz Abd El Ghany, et al.. (2014). Recombinations in Staphylococcal Cassette Chromosome mec Elements Compromise the Molecular Detection of Methicillin Resistance in Staphylococcus aureus. PLoS ONE. 9(6). e101419–e101419. 47 indexed citations

16.

Kaufmann, Mary E., et al.. (2009). Rapid identification of uropathogenic Escherichia coli of the O25:H4-ST131 clonal lineage using the Diversi-Lab repetitive sequence-based PCR system. Clinical Microbiology and Infection. 16(3). 232–237. 32 indexed citations

17.

Craddock, Charles, Patrick Chu, Andrew Dodgson, et al.. (2009). Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex. Expert Opinion on Drug Safety. 9(1). 139–147. 10 indexed citations

18.

Dodgson, Andrew, Claude Pujol, Michael A. Pfaller, David W. Denning, & David R. Soll. (2005). Evidence for recombination in Candida glabrata. Fungal Genetics and Biology. 42(3). 233–243. 47 indexed citations

19.

Lockhart, Shawn R., Claude Pujol, Andrew Dodgson, & David R. Soll. (2005). Deoxyribonucleic Acid Fingerprinting Methods for <I>Candida</I> Species. Humana Press eBooks. 118. 15–26. 3 indexed citations

20.

Bayat, Ardeshir, Hassan Shaaban, Andrew Dodgson, & Ken Dunn. (2003). Implications for Burns Unit design following outbreak of multi-resistant Acinetobacter infection in ICU and Burns Unit. Burns. 29(4). 303–306. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact